BioCentury
ARTICLE | Company News

Genetics Institute deal

February 21, 1995 8:00 AM UTC

GENIZ will receive a $12.5 million up front payment, and can achieve annual milestone payments of $12.5 million, $17.5 million and $7.5 million beginning June 30, 1996.

The companies will share profits on a predetermined basis and will jointly fund an independent institute dedicated to medical education in the field of biological reconstruction. GENIZ retains the exclusive right to manufacture rhBMP for Danek. ...